The primary objective of EPICLUSTER is to establish a collaborative framework for the coordinated actions of epilepsy research in Europe, based around shared partnerships and research priorities.
Key objectives are:
Maintaining the cooperation started under EpiXchange that brought together several large-scale epilepsy research projects and bring in new partnerships/projects and stakeholders
Agree shared priorities and work toward addressing these including in the area of (1) data sharing (large scale sequencing, preclinical, clinical data), (2) preclinical studies and improving translation, (3) access and sharing of research infrastructures and training.
Develop and pursue funding of joint research programmes of scale in Europe and beyond.
The Cluster’s leadership team is comprised of 10 internationally recognized scientists and clinicians in the field and the leaders of the seven projects that came together under EpiXchange as well as leaders from patient and professional organisations (see below). Collectively, they have supervised over 250 doctoral and postdoctoral researchers, contributing to over 2500 publications on the topic of mechanisms, treatment and biomarkers of epilepsy. Emphasising their excellence, the average H-index is over 50 and average over 13000 citations. Several are Directors of major national research centres (e.g. Henshall, FutureNeuro) and lead Task Forces under the auspices of the ILAE’s Commissions.
More info about epilepsy:
A series of four events will be run
EPI-cluster leadership
|
|
|
|||
|---|---|---|---|---|---|
| David C. Henshall, PhD
(Coordinator) RCSI/FutureNeuro |
Basic/translational neuroscience
Mechanisms, treatment & biomarkers of |
Coordinator, EpimiRNA | |||
| Renzo Guerrini, MD
Univ. Verona |
Genetics of epilepsy
Epileptic encephalopathies |
Coordinator, DESIRE | |||
| Sergiusz Jozwiak, MD
Univ. Warsaw |
Clinical neurology/epileptologist (paediatrics)
Tuberous sclerosis complex |
Coordinator, EPI-STOP | |||
| Merab Kokaia, PhD
Lund University |
Basic/translational neuroscience
Gene therapy |
Coordinator, EPI-TARGET | |||
| Asla Pitkanen, MD, PhD
U. E. Finland/Kuopio |
Basic/translational neuroscience
Mechanisms, treatment & biomarkers of acquired epilepsy |
Past-Secretary FENS, EPI-TARGET WP leader | |||
| Sanjay Sisodiya, MD, PhD
University College London |
Clinical neurology/epileptologist
Genetics of epilepsy |
Coordinator, Epi-PGX | |||
| Michele Simonato, MD
U. Ferrara/U. San Raf. |
Basic/translational neuroscience
Mechanisms, treatment & biomarkers of epilepsy |
Coordinator, EpiXchange IAPP | |||
| J. Helen Cross, MD, PhD
University College London/GOSH |
Clinical neurology/epileptologist (paediatrics)
Patient treatment and epilepsy care |
Coordinator, Epi-CARE, ILAE President-elect | |||
| Philippe Ryvlin, MD
U. Lausanne/CHUV |
Clinical neurology/epileptologist (adult) | ILAE Executive Europe, Lancet Commission |
Interested in joining EPI-CLUSTER? Please contact ebra@braincouncil.eu for more information.